Research on lung cancer screening behaviors and outcomes in high-risk individuals in Taiwan
Official title: Taiwan Real-world Low-dose Computed Tomography Screening behavIor and Outcome Research for High Risk Subjects Based on Health Promotion Administration-part A: Questionnaire Survey -Part B: LDCT Screening Outcome and Management
Run by Chung Shan Medical University · NCT05557487 · Data updated 2026-11-12
This study looks at how high-risk individuals in Taiwan, like smokers or those with a family history of lung cancer, are getting screened for lung cancer using low-dose CT scans to see how effective these screenings are.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 20 Years to 80 Years |
| Sex | All |
| Enrollment | 6618 (estimated) |
| Sponsor | Chung Shan Medical University Academic / other |
| Locations | 7 sites (Taichung, Taiwan and 6 other locations) |
| Status | Recruiting |
| Started | December 15, 2022 |
| Main results expected | December 31, 2025 |
| Study ends | December 31, 2028 |
| Registry record updated | September 10, 2025 |
| Trial ID | NCT05557487 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study include individuals aged 50 to 80 with a history of heavy smoking, first-degree relatives of lung cancer patients, or those exposed to significant environmental or occupational risks.
✕Probably not a fit
Patients who are not considered high-risk for lung cancer, such as lifelong non-smokers without family history or significant environmental exposure, may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study focuses on understanding the behaviors and outcomes of lung cancer screening among high-risk individuals in Taiwan, particularly those with a history of smoking, family history of lung cancer, or exposure to environmental pollutants. It utilizes low-dose computed tomography (LDCT) as a screening method to identify lung cancer in these populations. The study aims to gather real-world data to inform better screening strategies tailored to the unique risk profiles of participants, especially in the context of East Asian demographics. By analyzing the outcomes of these screenings, the research seeks to improve early detection and prevention efforts for lung cancer.
Why it matters
Potential benefit: If successful, this study could lead to improved screening strategies and early detection of lung cancer in high-risk populations, potentially reducing mortality rates.
How similar studies have gone: Other studies focusing on targeted lung cancer screening in high-risk populations have shown promise, indicating that tailored approaches can lead to better outcomes.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Group 1: Previous heavy smokers Age 50 to 80 years, meet both criteria in the followings. 1. Cigarette smoking of at least 20 pack-years 2. With successful smoking cessation history (stopping smoking for more than 6 months), but less than 15 years Group 2: First-degree relatives of lung cancer patients 1. aged more than 50 years 2. age less than 50 years old, but older than the age at diagnosis of the youngest lung cancer proband in the family Group 3: With other high-risk occupational or environmental factors Age 50 to 80 years, meet one or more of the following criteria. 1. air-pollution exposed occupations (such as traffic policemen, and street cleaners….) for at least 10 years 2. cooking index ≥ 110, defined as 2/7 \* days cooking by pan frying, stir-frying, or deep frying in one week \* years cooking. 3. cooking without using ventilation for more than 20 years 4. history of pulmonary tuberculosis and complete anti-tuberculosis treatment with intervals more than 5 years before this study Exclusion Criteria: 1. previous history of lung cancer 2. another malignancy except for cervical carcinoma in situ or non-melanomatous carcinoma of the skin within 5 years 3. an inability to tolerate transthoracic procedures or thoracotomy 4. chest CT examination was performed within 18 months 5. hemoptysis of unknown etiology within one month 6. body weight loss of more than 6 kg within one year without an evident cause 7. a known pregnancy 8. Not capable of understanding or responding to the written questionnaire even through the help from the study team
Where it's running
-
Chung Shan Medical University
Taichung, Taiwan, Taiwan Recruiting -
National Taiwan University Hospital Hsin-Chu Branch
Hsinchu, Taiwan Recruiting -
Hualien Tzu Chi Hospital
Hualien City, Taiwan Recruiting -
Kaohsiung Medical University Chung-Ho Memorial Hospital
Kaohsiung City, Taiwan Recruiting -
National Taiwan University Hospital
Taipei, Taiwan Recruiting -
E-Da Hospital
Kaohsiung City, Taiwan Not yet recruiting
Show 1 more location
-
Ministry of Health and Welfare Shuang-Ho Hospital
New Taipei City, Taiwan Not yet recruiting
Study contacts
- Study coordinator: GeeChen Chang, MD. PhD
- Email: geechen@gmail.com
- Phone: +886-4-24739595
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Collecting biospecimens and health data from people having low-dose CT lung screening
This project will collect blood, urine, tissue, imaging, and questionnaire data from people getting LDCT lung screening to try to improve how well we predict who will develop lung cancer.
-
Normal lung and heart function references for healthy US veterans who served in Southwest Asia
This study tests whether healthy veterans aged 24–68 who did not have exposure to airborne hazards have normal lung and heart function values that can serve as reference standards.
-
How exposure to heavy metals, nanoparticles, and emerging contaminants relates to allergic skin and systemic metal reactions
This project will test whether adults with allergic contact dermatitis or systemic metal allergies have different levels of heavy metals, nanoparticles, and related blood and urine markers compared with healthy adults.
-
Salivary IL-8 and Serum IL-6 as Biomarkers to Distinguish Oral Premalignant Disorders in Smokers and Never-Smokers
This study tests whether salivary IL-8 and blood IL-6 can help tell apart adults with oral premalignant conditions from those with healthy mouths, and whether smoking influences these markers.
-
ePRO in advanced lung cancer: emotional distress, brain metastasis, and symptom burden
This study tests how patients with advanced lung cancer—some with brain metastases—report emotional distress and symptoms over time using electronic questionnaires.
-
Access to multiple tobacco flavors to help adult cigarette smokers quit using e-cigarettes
This study tests whether giving adult smokers an e-cigarette with a choice of flavors helps them quit smoking by the end of 13 weeks.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.